Since PD-L1 is the major negative immune regulatory pathway upregulated by IFN-γ on tumor cells, once the PD-L1-/PD-1 interaction is masked, then it appears that the antitumor effects of IFN-γ dominate, selecting for IFN-γ-signaling-mutant tumor cells. This evidence concerns the gene IFNG and neoplasm.